TY  - JOUR
AU  - Ampuero, Javier
AU  - Reddy, K Rajender
AU  - Romero-Gomez, Manuel
PY  - 2016
DO  - 10.3748/wjg.v22.i22.5285
UR  - http://hdl.handle.net/10668/10175
T2  - World journal of gastroenterology
AB  - To address the therapeutic efficacy of various treatment regimens in genotype 3 selecting randomized clinical trials and prospective National Cohort Studies. (1) PEG-INF-based therapy including sofosbuvir (SOF) + RBV for 12 wk vs SOF + RBV 24 wk; (2)...
LA  - en
KW  - Daclatasvir
KW  - Genotype 3
KW  - Hepatitis C
KW  - Ledipasvir
KW  - Sofosbuvir
KW  - Administration, Oral
KW  - Antiviral Agents
KW  - Carbamates
KW  - Drug Resistance, Viral
KW  - Drug Therapy, Combination
KW  - Genotype
KW  - Hepacivirus
KW  - Hepatitis C
KW  - Humans
KW  - Imidazoles
KW  - Odds Ratio
KW  - Prospective Studies
KW  - Pyrrolidines
KW  - Randomized Controlled Trials as Topic
KW  - Ribavirin
KW  - Sofosbuvir
KW  - Sustained Virologic Response
KW  - Time Factors
KW  - Valine
TI  - Hepatitis C virus genotype 3: Meta-analysis on sustained virologic response rates with currently available treatment options.
TY  - research article
VL  - 22
ER  -